The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
复制标题
DOI:
10.1002/oby.21199
复制
发表时间:
2015-01-01
期刊:
影响因子:
6.9
通讯作者:
Poulain-Godefroy, Odile
中科院分区:
文献类型:
--
作者:
Favennec, Marie;Hennart, Benjamin;Poulain-Godefroy, Odile
ObjectiveThis study characterized the kynurenine pathway (KP) in human obesity by evaluating circulating levels of kynurenines and the expression of KP enzymes in adipose tissue.MethodsTryptophan and KP metabolite levels were measured in serum of individuals from the D.E.S.I.R. cohort (case-cohort study: 212 diabetic, 836 randomly sampled) and in women with obesity, diabetic or normoglycemic, from the ABOS cohort (n=100). KP enzyme gene expressions were analyzed in omental and subcutaneous adipose tissue of women from the ABOS cohort, in human primary adipocytes and in monocyte-derived macrophages.ResultsIn the D.E.S.I.R. cohort, kynurenine levels were positively associated with body mass index (BMI) (P=4.68 x 10(-19)) and with a higher HOMA2-IR insulin resistance index (P=6.23 x 10(-4)). The levels of kynurenine, kynurenic acid, and quinolinic acid were associated with higher BMI (P